Background and Study Aims: The nitinol stent is a self-expandable spir
al stent made of nickel-titanium alloy. We performed a pilot study to
evaluate the method of stent insertion and stent efficacy. Patients an
d Methods: Twenty-eight patients with irresectable malignancy had niti
nol stents inserted for obstructive jaundice due to distal biliary str
ictures. They were followed prospectively for a median of ten weeks (r
ange 1-48) until stent occlusion or death. All patients underwent sphi
ncterotomy prior to stent insertion. Stent deployment was assisted by
subsequent balloon dilation of the stent in two patients. Plastic sten
t insertion was used to temporarily brace the nitinol stent in another
three patients. Results: Short-term relief of jaundice was achieved i
n 20 of the 28 patients (71%). The remaining eight patients had persis
tent jaundice due to failure of stent insertion (three patients) or ea
rly stent dysfunction (five patients). Long-term success was achieved
in 12 of 28 patients (43%). Ten of the 12 patients died without compli
cations after a median of 13.5 weeks (range 3-48). One of the 12 patie
nts is still alive with the stent in place for 40 weeks, and one patie
nt underwent elective bypass surgery, and the stent was removed surgic
ally Eight of the 28 patients had recurrent symptoms due to late stent
dysfunction after a median of 19 weeks (range 6-32). Conclusions: Nit
inol stents are technically difficult to insert. The problem of stent
dysfunction (13 of 28, 46%) is not improved by the use of nitinol sten
ts. Whether improvement of the insertion technique and enhancement of
the expanding force of the stent may improve stent efficacy merits fur
ther evaluation.